Development of new enzyme-linked immunosorbent assay for oxidized lipoprotein(a) by using purified human oxidized lipoprotein(a) autoantibodies as capture antibody

2007 ◽  
Vol 385 (1-2) ◽  
pp. 73-78 ◽  
Author(s):  
Junjun Wang ◽  
Chunni Zhang ◽  
Jianbin Gong ◽  
Yanfei Zhu ◽  
Li Fu ◽  
...  
Keyword(s):  
Immunosorbent Assay ◽  
Enzyme Linked Immunosorbent Assay ◽  
Lipoprotein A ◽  
Oxidized Lipoprotein ◽  
Capture Antibody

A monoclonal-antibody-based enzyme-linked immunosorbent assay of lipoprotein(a)

1990 ◽  
Vol 36 (2) ◽  
pp. 192-197 ◽  
Author(s):  
W L Wong ◽  
D L Eaton ◽  
A Berloui ◽  
B Fendly ◽  
P E Hass
Keyword(s):  
Monoclonal Antibody ◽  
Immunosorbent Assay ◽  
Clinical Laboratory ◽  
Low Density Lipoprotein ◽  
Density Lipoprotein ◽  
Enzyme Linked Immunosorbent Assay ◽  
Apo B ◽  
Lipoprotein A ◽  
Premature Coronary Heart Disease ◽  
Large Populations

Abstract Lipoprotein(a) [Lp(a)] is a low-density lipoprotein (LDL)-like lipoprotein particle recently described as a risk factor for premature coronary heart disease, stroke, and atherosclerosis. Structurally, Lp(a) is similar to LDL in that it has comparable lipid composition and contains apolipoprotein B-100 (apo B-100). In addition, Lp(a) contains the glycoprotein apolipoprotein(a) [apo(a)], which is disulfide-linked to apo B-100. The recent awareness of a striking correlation between atherosclerosis and concentrations of Lp(a) in plasma prompted our development of an accurate quantitative assay for plasma Lp(a), a monoclonal-antibody-based enzyme-linked immunosorbent assay for Lp(a) that is shown to be sensitive, precise, and highly specific. The response to several isoforms of Lp(a) is linear, and as many as 80 samples can be quantified on one plate. This easily performed assay is suitable for use in the clinical laboratory and for screening large populations.

Lipoprotein(a) quantified by an enzyme-linked immunosorbent assay with monoclonal antibodies.

1989 ◽  
Vol 35 (7) ◽  
pp. 1380-1384 ◽  
Author(s):  
C Labeur ◽  
G Michiels ◽  
J Bury ◽  
D C Usher ◽  
M Rosseneu
Keyword(s):  
Monoclonal Antibody ◽  
Immunosorbent Assay ◽  
Plasma Cholesterol ◽  
Sample Pretreatment ◽  
Hdl Cholesterol ◽  
Normal Subjects ◽  
Enzyme Linked Immunosorbent Assay ◽  
Apo B ◽  
Lipoprotein A ◽  
Screening Programs

Abstract This new, sensitive, specific "sandwich"-type enzyme-linked immunosorbent assay (ELISA) for quantifying lipoprotein(a) [Lp(a)] in human serum and in ultracentrifugal lipoprotein fractions is based on use of a monoclonal antibody raised against apolipoprotein(a) as coating protein and a polyclonal antibody, raised against either apo B or against Lp(a) and conjugated with peroxidase, for detection of bound Lp(a). Mean intra- and interassay CVs for assay of 16 samples were 3.0% and 5.6%, respectively. Sample pretreatment with urea did not enhance Lp(a) immunoreactivity, and treatment with nonionic detergents decreased binding to the monoclonal antibody. Results correlated well (r = 0.99, n = 38) with those by radial immunodiffusion (RID). The ELISA assay, however, detects amounts corresponding to Lp(a) contents of 10 to 1000 mg/L in plasma samples diluted 1000-fold, compared with 100-500 mg/L for RID. For 92 normolipidemic subjects, the mean Lp(a) concentration was 120 (SD 130) mg/L. In patients undergoing coronary angiography, Lp(a) concentrations increased with the severity of the disease but were not correlated with either HDL cholesterol, triglycerides, apo A-I, or apo B, and only weakly with plasma cholesterol and apo A-II. These two correlations were even weaker in normal subjects, and only the correlation with total cholesterol was valid. Lp(a), measured at birth and at seven days and six months, steadily increased with age. This assay is well suited for measuring Lp(a) in plasma and in lipoprotein fractions and also for screening programs evaluating this significant genetic risk factor for the development of atherosclerosis.

Development of an enzyme-linked immunosorbent assay of apolipoprotein E-AII complex in plasma

1991 ◽  
Vol 37 (9) ◽  
pp. 1645-1648 ◽  
Author(s):  
M Tozuka ◽  
Y Yoshida ◽  
J Tanigami ◽  
M Miyachi ◽  
T Katsuyama ◽  
...  
Keyword(s):  
Immunosorbent Assay ◽  
Lipoprotein Metabolism ◽  
Enzyme Linked Immunosorbent Assay ◽  
Simple Method ◽  
Coefficients Of Variation ◽  
Apo E ◽  
Rabbit Igg ◽  
Reference Serum ◽  
Capture Antibody

Abstract Measurement of apolipoprotein (apo) E-AII complex in human plasma is important in determining the role of apoE in lipoprotein metabolism. In this paper, we demonstrate a new and simple method to determine apoE-All complex by using an enzyme-linked immunosorbent assay. Anti-apoE IgG (goat) was used as a capture antibody, and captured apoE-All complexes were detected by an anti-apoAll (rabbit) horseradish peroxidase-conjugated anti-rabbit IgG (goat) system. With this method, apoE-All complex was specifically determined without the interference of apoAll and was not affected by apoE monomer less than 250 mg/L. The content of the complex in reference serum, a normolipidemic serum pooled from five subjects with phenotype E3/E3, was arbitrarily defined as 100%. The coefficients of variation were 3.5%-6.3% within assay and 8.8%-11.6% between assays.

Monoclonal Antibody–Based Sandwich Enzyme-Linked Immunosorbent Assay for Sensitive Detection of Prohibited Ruminant Proteins in Feedstuffs

2004 ◽  
Vol 67 (3) ◽  
pp. 544-549 ◽  
Author(s):  
FUR-CHI CHEN ◽  
Y.-H. PEGGY HSIEH ◽  
ROGER C. BRIDGMAN
Keyword(s):  
Immunosorbent Assay ◽  
Troponin I ◽  
Enzyme Linked Immunosorbent Assay ◽  
Spongiform Encephalopathy ◽  
Animal Products ◽  
Meat Meal ◽  
Heat Treated ◽  
Capture Antibody ◽  
Ruminant Meat ◽  
Feed Samples

Regulations aimed to control the epidemic of bovine spongiform encephalopathy have banned the use of certain animal products, i.e., ruminant meat and bone meals, in ruminant animal feeds. A sensitive enzyme-linked immunosorbent assay has been developed to detect prohibited bovine and ovine muscles in feedstuffs. The assay utilizes a pair of monoclonal antibodies (MAbs) against skeletal troponin I (TnI). MAb 5G9, specific to bovine and ovine TnI, was used as the capture antibody and the biotin-conjugated MAb 2G3, reacting to all heterologous TnI, was used as the detection antibody. Quantitative procedures were applied to samples containing 5, 0.5, and 0.05% (wt/wt) of heat-treated (132°C/2 bar, 2 h) bovine and ovine meat meals in three different feeds, coexisting with porcine, chicken, or turkey meat meal. The presence of these nonprohibited species did not affect the detection of bovine and ovine meat meals in the feed samples (P > 0.05). Quantitative determinations of extractable bovine and ovine TnI, with a detection limit of 5.0 and 4.0 ng/ml, respectively, were achieved when the matching feed matrixes were used in the calibration curves. This new assay provides a rapid and reliable way to detect animal protein products containing a trace amount of bovine or ovine muscle tissue in feedstuffs.

Enzyme-linked immunosorbent assay of lipoprotein(a) in serum and cord blood

1988 ◽  
Vol 177 (1) ◽  
pp. 31-40 ◽  
Author(s):  
Akira Abe ◽  
Satoshi Maeda ◽  
Kazuhiko Makino ◽  
Mitsuru Seishima ◽  
Kuniyasu Shimokawa ◽  
...  
Keyword(s):  
Cord Blood ◽  
Immunosorbent Assay ◽  
Enzyme Linked Immunosorbent Assay ◽  
Lipoprotein A

scholarly journals Fenobody and RANbody-based sandwich enzyme-linked immunosorbent assay to detect Newcastle disease virus

2020 ◽  
Author(s):  
Pinpin Ji ◽  
Jiahong Zhu ◽  
Xiaoxuan Li ◽  
Wenqi Fan ◽  
Qianqian Liu ◽  
...  
Keyword(s):  
Newcastle Disease Virus ◽  
Disease Virus ◽  
Immunosorbent Assay ◽  
Newcastle Disease ◽  
Tertiary Structure ◽  
Sandwich Elisa ◽  
Enzyme Linked Immunosorbent Assay ◽  
Permanent Storage ◽  
Capture Antibody ◽  
The Cost

Abstract Background: Traditional sandwich enzyme-linked immunosorbent assay (ELISA) using polyclonal and monoclonal antibodies as reagents presents several drawbacks, including limited amounts, difficulty in permanent storage, and required use of a secondary antibody. Nanobodies can be easily expressed with different systems and fused with several tags in their tertiary structure by recombinant technology, thus offering an effective detection method for diagnostic purposes. Recently, the fenobody (ferritin-fused nanobody) and RANbody (nanobody-fused reporter) have been designed and derived from the nanobody for developing the diagnostic immunoassays. However, there was no report about developing the sandwich ELISA using the fenobody and RANbody as pairing reagents.Results: A platform for developing a sandwich ELISA utilizing fenobody as the capture antibody and RANbody as the detection antibody was firstly designed in the study. Newcastle disease virus (NDV) was selected as the antigen, from which 13 NDV-specific nanobodies were screened from an immunized Bactrian camel. Then, 5 nanobodies were selected to produce fenobodies and RANbodies. The best pairing of fenobodies (NDV-fenobody-4, 800 ng/well) and RANbodies (NDV-RANbody-49, 1:10) was determined to develop the sandwich ELISA for detecting NDV. The detection limits of the assay were determined to be 22 of hemagglutination (HA) titers and 10 ng of purified NDV particles. Compared with two commercial assays, the developed assay shows higher sensitivity and specificity. Meanwhile, it exhibits 98.7% agreement with the HA test and can detect the reference NDV strains belonging to Class II but not Class I. Conclusions: In the presented study, the 13 anti-NDV nanobodies binding the NDV particles were first produced. Then, for the first time, the sandwich ELISA to detect the NDV in the different samples has been developed using the fenobody and RANbody as reagents derived from the nanobodies. Considering the rapidly increasing generation of nanobodies, the platform can reduce the cost of production for the sandwich ELISA and be universally used to develop assays for detecting other antigens.

Sign in / Sign up

Export Citation Format

Share Document